Overview
Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.
Download and listen wherever you listen to podcasts (Apple Podcasts, Google Podcasts, Tune In, Listen Notes, Podcast Addict).
To listen in AGA University, click Launch Course.
Episode breakdown:
Episode 1: Diversity in IBD Trials: Start with our workforce
Our hosts Drs. Erin Forster and Ayanna Lewis are joined by guests Drs. Freddy Caldera and Jana Al Hashash to discuss how diversifying participation in clinical trials starts with diversifying our workforce.
Episode 2: Diversity in IBD Trials: Changing how we talk to patients
Drs. Erin Forster and Ayanna Lewis are joined by guest Melodie Narain-Blackwell, the founder and president of Color of Crohn’s & Chronic Illness (COCCI) to discuss how to talk about clinical research with patients.
Episode 3: Diversity in IBD Trials: Bringing research to the community
Co-host Dr. Erin Forster is joined by guest Kenneth Getz, founder of CISCRP to discuss how to bring awareness of and education on clinical research to the community.
Episode 4: Diversity in IBD Trials: The community GI perspective
Co-host Dr. Ayanna Lewis is joined by guest Dr. Erica Cohen, to discuss the community GI’s perspective on clinical trials.
Episode 5: Diversity in IBD Trials: The role of the CRO
Co-host Dr. Erin Forster is joined by guest Dr. Gabriela Radulescu to discuss how contract research organizations (CROs) are working with investigators and sponsors to increase the diversity of patients enrolling in clinical trials.
Episode 6: Diversity in IBD Trials: How artificial intelligence may help
In this supersized episode, co-host Dr. Ayanna Lewis is joined by guest Dr. Ryan Stidham to explore how artificial intelligence may help address challenges with participant recruitment for clinical trials, while also discussing the role of AI in the field of gastroenterology more broadly.
Supporter acknowldegement
This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Podcast | Episode 1 - Diversity in IBD Trials- Start with our workforce
35 mins
Podcast | Episode 2 - Diversity in IBD Trials- Changing how we talk to patients
32 mins
Podcast | Episode 3 - Diversity in IBD Trials- Bringing research to the community
23 mins
Podcast | Episode 4 - Diversity in IBD Trials- The community GI perspective
21 mins
Podcast | Episode 5 - Diversity in IBD Trials- The role of the CRO
29 mins
Podcast | Episode 6 - Diversity in IBD Trials- How artificial intelligence may help
52 mins
Course Faculty
Host
Ayanna Lewis, MD
Assistant Professor
Division of Gastroenterology Icahn School of Medicine at Mount Sinai New York, NY
Erin Forster, MD, MPH
Associate Professor
Division of Gastroenterology and Hepatology Medical University of South Carolina Charleston, SC